Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults

Free Radical Biology and Medicine

Volumn 28, Issue 7, 2000, Pages 1100-1105

  Raitakari, Olli T ^a,c   McCredie, Robyn J ^a   Witting, Paul ^b   Griffiths, Kaye A ^a   Letters, Jacinta ^b   Sullivan, David ^a   Stocker, Roland ^b   Celermajer, David S ^a,d  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antioxidants; Dyslipidemia; Free radicals; Ultrasound; Vascular reactivity

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UBIQUINONE;

ADULT; ARTERY DILATATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DILATATION, PATHOLOGIC; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; UBIQUINONE;

EID: 0034067098     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00201-X     Document Type: Article

References (52)

1. Langsjoen P.H., Langsjoen A.M. Coenzyme Q10 in cardiovascular disease with emphasis on heart failure and myocardial ischaemia. Asia Pacific Heart J. 7:1998;160-168.
2. Ernster L., Forsmark P., Nordenbrand K. The mode of action of lipid-soluble antioxidants in biological membranes relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles . Biofactors. 3:1992;241-248.
3. 10. Proc. Natl. Acad. Sci. U.S.A. 82:1985;4240-4244.
4. 10 illuminated by meta-analyses of clinical trials. Mol. Aspects Med. 18:(Suppl.):1997;159-168.
5. 10 on exercise tolerance in chronic stable angina pectoris. Am. J. Cardiol. 56:1985;247-251.
6. 10 during heart surgery. Clin. Investig. 71:(Suppl. 8):1993;155-161.
7. Anderson T.J., Meredith I.T., Charbonneau F., Yeung A.C., Frei B., Selwyn A.P., Ganz P. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation. 93:1996;1647-1650.
8. Raitakari O.T., Pitkänen O.-P., Lehtimäki T., Lahdenperä S., Iida H., Ylä-Herttuala S., Luoma J., Mattila K., Nikkari T., Taskinen M.-R., Viikari J.S.A., Knuuti J. In vivo LDL oxidation relates to coronary reactivity in young men. J. Am. Coll. Cardiol. 30:1997;97-102.
9. Stocker R., Frei B. Endogenous antioxidant defenses in human blood plasma. Sies H. Oxidative stress oxidants and antioxidants . 1991;213-243 Academic Press, London.
10. Gey K.F., Puska P., Jordan P., Moser U.K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53:1991;326S-334S.
11. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328:1993;1450-1456.
12. Kagan V.E., Serbinova E.A., Forte T., Scita G., Packer L. Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33:1992;385-397.
13. Bowry V.W., Stocker R. Tocopherol-mediated peroxidation the pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein . J. Am. Chem. Soc. 115:1993;6029-6044.
14. Thomas S.R., Neuzil J., Stocker R. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation. Arterioscler. Thromb. Vasc. Biol. 16:1996;687-696.
15. Adams M.R., Robinson J., Sorensen K.E., Deanfield J.E., Celermajer D.S. Normal ranges for brachial artery flow-mediated dilatation a non-invasive ultrasound test of arterial endothelial function . J. Vasc. Invest. 2:1996;146-150.
16. Yamamoto Y., Brodsky M.H., Baker J.C., Ames B.N. Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography. Anal. Biochem. 160:1987;7-13.
17. Friedewald W.T., Levy R., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
18. Barcley L.R.C., Locke S.J., MacNeil J.M., VanKessel J. Autoxidation of micelles and model membranes quantitative kinetic measurements can be made by using either water-soluble or lipid-soluble initiators with water-soluble or lipid-soluble chain-breaking antioxidants . J. Am. Chem. Soc. 106:1984;2479-2481.
19. Sattler W., Mohr D., Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC post-column chemiluminescence. Methods. Enzymol. 233:1994;469-489.
20. Witting P.K., Mohr D., Stocker R. Assessment of pro- and anti-oxidant activity of vitamin E in human low density lipoprotein and plasma. Methods. Enzymol. 299:1998;362-375.
21. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., Deanfield J.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
22. Celermajer D.S., Sorensen K.E., Georgakopoulos D., Bull C., Thomas O., Robinson J., Deanfield J.E. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 88:1993;2149-2155.
23. Sorensen K.E., Celermajer D.S., Spiegelhalter D.J., Georgakopoulos D., Robinson J., Thomas O., Deanfield J.E. Non-invasive measurement of endothelium-dependent arterial responses in man accuracy and reproducibility . Br. Heart J. 74:1995;247-253.
24. Anderson T.J., Uehata A., Gerhard M.D., Meredith I.T., Knab S., Delagrange D., Lieberman E.H., Ganz P., Creager M.A., Yeung A.C., Selwyn A.P. Close relationship of endothelial function in the human coronary and peripheral circulations. J. Am. Coll. Cardiol. 26:1995;1235-1241.
25. Neunteufl T., Katzenschlager R., Hassan A., Klaar U., Schwarzacher S., Glogar D., Bauer P., Weidinger F. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis. 129:1997;111-118.
26. Armitage, P.; Berry, G. Statistical methods in medical research. (3rd ed.). Cambridge: Blackwell Science Ltd.; 1994.
27. Simon B.C., Cunningham L.D., Cohen R.A. Oxidized low-density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary arteries. J. Clin. Invest. 86:1990;75-79.
28. 10 results in increased of ubiquinol-10 with circulating lipoproteins and increased resistance of human low density lipoprotein to the initiation of lipid peroxidation. Biochim. Biophys. Acta. 1126:1992;247-254.
29. 10 and vitamin E on peroxidation of human low density subfractions. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9388-9391.
30. Vita, J. A.; Frei, B.; Holbrook, M.; Gokce, N.; Leaf, C.; Keaney, J. F., Jr. L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J. Clin. Invest. 101:1408-1414; 1998.
31. Jackson T.S., Xu A., Vita J.A., Keaney J.F. Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ. Res. 83:1998;916-922.
32. Heitzer T., Just H., Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 94:1996;6-9.
33. Ting H.H., Timimi F.K., Haley E.A., Roddy M.-A., Ganz P., Creager M.A. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 95:1997;2617-2622.
34. Solzbach U., Horning B., Jeserich M., Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation. 96:1997;1513-1519.
35. Levine G.N., Frei B., Koulouris S.N., Gerhard M.D., Keaney J.F. Jr, Vita J.A. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 93:1996;1107-1113.
36. Zhang Y., Aberg F., Appelkvist E.-L., Dallner G., Ernster L. Uptake of dietary coenzyme Q supplement is limited in rats. J. Nutr. 125:1995;446-453.
37. Minor R.L.J., Myers P.R., Guerra R., Bates J.N., Harrison D.G. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J. Clin. Invest. 86:1990;2109-2116.
38. Celermajer D.S. Endothelial dysfunction Does it matter? Is it reversible? J. Am. Coll. Cardiol. 30:1997;325-333.
39. Joannides R., Haefeli W.E., Linder L., Richard V., Bakkali E.H., Thuillez C., Luscher T.F. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 91:1995;1314-1319.
40. Lieberman E.H., Gerhard M.D., Uehata A., Selwyn A.P., Ganz P., Yeung A.C., Creager M.A. Flow-induced vasodilation of the human brachial artery is impaired in patients less than 40 years of age with coronary artery disease. Am. J. Cardiol. 78:1996;1210-1214.
41. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
42. Hornig B., Arakawa N., Kohler C., Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation. 97:1998;363-368.
43. Gilligan D.M., Sack M.N., Guetta V., Casino P.R., Quyymi A.A., Rader D.J., Panza J.A., Cannon R.O. III. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J. Am. Coll. Cardiol. 24:1994;1611-1617.
44. Simons L.A., Von Koningsmark M., Simons J., Stocker R., Celermajer D.S. Vitamin E ingestion does not improve endothelial dysfunction in older adults. Atherosclerosis. 143:1999;193-199.
45. Raitakari, O. T.; Adams, M. R.; McCredie, R. J.; Griffiths, K. A.; Stocker, R.; Celermajer, D. S. Oral vitamin C and endothelial function in smokers: acute improvement, but no sustained beneficial effect. J. Am. Coll. Cardiol. in press; 2000.
46. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N. Engl. J. Med. 332:1995;488-493.
47. Neunteufl T., Kostner K., Katzenschlager R., Zehetgruber M., Maurer G., Weidinger F. Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men. J. Am. Coll. Cardiol. 32:1998;711-716.
48. Gokce N., Keaney J.F. Jr, Frei B., Holbrook M., Olesiak M., Zachariah B.J., Leewenburgh C., Heinecke J.W., Vita J.A. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 99:1999;3234-3240.
49. Motoyama T., Kawano H., Kugiyama K., Hirashima O., Ohgushi M., Tsunoda R., Moriyama Y., Miyao Y., Yoshimura M., Ogawa H., Yasue H. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J. Am. Coll. Cardiol. 32:1998;1672-1679.
50. Heitzer T., Ylä-Herttuala S., Wild E., Luoma J., Drexler H. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J. Am. Coll. Cardiol. 33:1999;499-505.
51. Koh K.K., Blum A., Hathaway L., Mincemoyer R., Csako G., Waclawiw M.A., Panza J.A., Cannon R.O. III. Vascular effects of estrogen and vitamin E therapies in postmenopausal women. Circulation. 100:1999;1851-1857.
52. Murakami T., Mizuno S., Kaku B. Clinical morbidities in subjects with Doppler-evaluated endothelial dysfunction of coronary artery (abstract). J. Am. Coll. Cardiol. 31:1998;419A.